
mRNA Cancer Vaccine Shows Promise for Pancreatic Cancer
A custom-made messenger RNA (mRNA) vaccine plus an immune checkpoint inhibitor appears to reduce the risk of pancreatic cancer recurrence for at least three years after surgery, according to results from a small clinical trial published in Nature. “The …